Dr. Sandhyasri Panda, Dr. Apurva Ganeshprakash Gupta, Dr. P Prabhakar Varma and Dr. T Venkateswara Rao
Introduction: Increasing number of genital tuberculosis (GTB) were reported post COVID pandemic, in year 2022.This study aims to estimate the incidence, presentations, diagnostic modalities and treatment plan adopted in our tertiary care centre for Female GTB.
Methods: This is a study between 2014 to 2022 from DEPT of OBGYN all cases of FGTB were analysed, supplementary data were collected from departments of Pulmonary medicine, general medicine, DVL, General surgery, Urology and TB core committee meetings. Data analysis was done in proportion and percentages.
Results: Ten out of 1342 were FGTB, making an incidence of 0.74%.In GUTB, men: women was 1:5. In 2022 (Post COVID pandemic) 30% of FGTB were reported. Ninety percent were low SE class; mean age was 30.6years; common presenting symptoms were pain abdomen, menstrual disorder, TO mass each being 60%; infertility being 20% and pregnancy with urogenital TB 10%; 30% presented with concomitant PTB. Diagnosis was established by bacteriology in 40%, histopathology in 40% including a case of endometrial osseous metaplasia, imaging in 20%. Overall, imaging was supportive in diagnosis in 90%. Menstrual abnormality noted were either hypomenorrhea (66%) or ammenorhea (34%).
Conclusion: Although menstrual abnormalities, TO pathology, and infertility are common presentations, GUTB should be considered as a diagnosis in pregnant women with sterile pyuria. Normal menstruation returns ≈four weeks of ATT among patients of PTB and 6monthsthose with endometrial involvement. The choice of treatment for TO mass in FGTB is ATT and broad spectrum antibiotics.
Pages: 04-09 | 493 Views 253 Downloads